Measurement of free fatty acid kinetics during non-equilibrium tracer conditions in man: implications for the estimation of the rate of appearance of free fatty acids

Eur J Clin Invest. 1998 Feb;28(2):108-14. doi: 10.1046/j.1365-2362.1998.00249.x.

Abstract

Background: This study aimed to document the applicability and variability of free fatty acid (FFA) kinetic parameters during non-equilibrium and equilibrium tracer conditions in man.

Methods: FFA kinetic parameters were assessed after an overnight fast in six healthy non-obese and three obese subjects as well as in three patients with non-insulin-dependent diabetes mellitus (NIDDM) by infusion of [14C]-palmitate of 60 min (study A) and 10 min duration (study B).

Results: The kinetic parameters estimated from the upstroke and downstroke of the plasma FFA specific activity curve (non-equilibrium) were not statistically different within studies A and B. Furthermore, there were no significant differences in any of the FFA kinetic parameters between studies A and B. The averaged plasma levels of FFA obtained during the up- and downstroke from studies A and B were higher in obese subjects and NIDDM patients than in non-obese subjects (P < 0.01). The averaged total rate of appearance (TRa) of FFA was higher in obese subjects than in non-obese subjects (P < 0.02). The TRa and metabolic clearance rate (MCR), estimated from non-equilibrium conditions, were about 25% higher than the apparent values obtained from steady-state measurement in all subjects combined (P < 0.01), suggesting considerable recirculation of label from hydrolysis of labelled esterified fatty acids. Indeed, in three non-obese subjects, the radiolabel in esterified fatty acids was approximately 50% of labelled FFA at 60 min of label infusion. The coefficients of variation of the kinetic parameters were consistently larger in study A than in study B.

Conclusion: FFA kinetic parameters can be estimated with sufficient precision using non-equilibrium data from short-term labelled palmitate infusion. Short-term label infusion has the advantage that label recirculation is prevented and exposure to radiation is limited.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carbon Radioisotopes
  • Diabetes Mellitus, Type 2 / blood
  • Fatty Acids, Nonesterified / blood
  • Fatty Acids, Nonesterified / pharmacokinetics*
  • Half-Life
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Obesity / blood
  • Palmitic Acid / pharmacokinetics
  • Radioactive Tracers
  • Reproducibility of Results
  • Time Factors

Substances

  • Carbon Radioisotopes
  • Fatty Acids, Nonesterified
  • Radioactive Tracers
  • Palmitic Acid